Aier Eye Hospital Group News

Aier Ophthalmology (300015): A ten-year journey of pioneering new territory at home and abroad continues

Western SecuritiesDec 29, 2024 11:22

Research Report Gold Digging | Yongxing Securities: Aier Eye Hospital Group's performance has considerable elasticity, first giving a "shareholding" rating.

Gelonghui FinanceNov 28, 2024 14:25

Aier Ophthalmology (300015) 2024 Q3 Report Performance Review: Steady Operation Expecting Consumption Recovery

Yongxing SecuritiesNov 27, 2024 19:42

Aier Ophthalmology (300015): Global Ophthalmology Medical Services Market Leader Brand Influence Continues to Grow

Open Source SecuritiesNov 25, 2024 07:12

Aier Ophthalmology (300015): Strengthening the domestic+international dual cycle and steadily advancing the “1+8+N” strategy

Fangzheng SecuritiesNov 18, 2024 00:00

Aier Ophthalmology (300015): Performance is under pressure, looking forward to a recovery in consumption and optimistic about long-term trends

Northeast SecuritiesNov 9, 2024 00:00

Aier Ophthalmology (300015): Resilient management and waiting for consumption to recover

Ping An SecuritiesNov 1, 2024 13:12

Aier Ophthalmology (300015): Short-term growth is pressured, hospital acquisitions continue to advance in an orderly manner

guosenOct 31, 2024 16:22

Aier Ophthalmology (300015): Short-term external causes will not change the company's long-term positive trend

htscOct 30, 2024 00:00

Nomura Downgrades Aier Eye Hospital Group to Neutral From Buy, Adjusts Price Target to 15.40 Yuan From 13.70 Yuan

MT NewswiresOct 25, 2024 15:37

Aier Ophthalmology (300015): Net profit returned to mother increased 20% year-on-year in the first half of the year, and the layout of medical networks at home and abroad continued to improve

Sep 10, 2024 07:36

Aier Ophthalmology (300015): Operation remains resilient, and acquisitions of extracorporeal hospitals are progressing steadily

zhongtai SecuritiesSep 7, 2024 00:00

Aier Ophthalmology (300015): Focus on M&A expectations for external funds and overseas expansion

Sep 1, 2024 00:00

Aier Ophthalmology (300015): The core business is growing steadily, and the scale of the medical network continues to expand

Aug 29, 2024 07:51

Aier Ophthalmology (300015): The hierarchical chain advantage continues to consolidate domestic and international two-way linkages

Aug 27, 2024 07:36

Citi Downgrades Aier Eye Hospital Group to Sell From Neutral; Price Target Is 7 Yuan

MT NewswiresAug 26, 2024 17:28

Aier Ophthalmology (300015): 1H24 results are in line with expectations, rapid growth in overseas regions

Aug 26, 2024 16:31

Aier Ophthalmology (300015) 2024 Semi-Annual Report Review: The semi-annual report meets expectations and is optimistic about the company's long-term development

Aug 26, 2024 14:01

Aier Ophthalmology (300015) 2024 Interim Report Review: Performance growth has slowed down due to external circumstances

Aug 26, 2024 13:41

Aier Ophthalmology (300015): Performance is slightly lower than expected, optimistic about the long-term development of leading ophthalmology companies

Aug 26, 2024 07:31